XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.2
EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2021
RSAs    
Shares    
Number of nonvested shares outstanding, beginning 406,001  
Nonvested shares granted 0  
Nonvested shares vested (178,169)  
Nonvested shares forfeited (34,167)  
Number of nonvested shares outstanding, ending 193,665  
Unrecognized stock-based compensation expense $ 615  
Weighted Average Grant Date Fair Value    
Weighted average exercise price outstanding, beginning (in usd per share) $ 4.02  
Weighted average exercise price outstanding, nonvested options granted (in usd per share) 0  
Weighted average exercise price outstanding, options vested (in usd per share) 4.10  
Weighted average exercise price outstanding, options forfeited (in usd per share) 4.38  
Weighted average exercise price outstanding, ending (in usd per share) $ 3.87  
Weighted average remaining vesting period 1 year 6 months  
RSUs    
Shares    
Number of nonvested shares outstanding, beginning 450,000  
Nonvested shares vested (491,520)  
Nonvested shares forfeited   (450,000)
Number of nonvested shares outstanding, ending 137,577  
Unrecognized stock-based compensation expense $ 5,566  
Restricted Shares    
Nonvested restricted stock outstanding, beginning balance (in shares) 842,302  
Nonvested restricted stock granted (in shares) 1,116,875  
Nonvested restricted stock vested (in shares) (313,351)  
Nonvested restricted stock forfeited (in shares) (223,002)  
Nonvested restricted stock outstanding, ending balance (in shares) 1,422,824  
Weighted Average Grant Date Fair Value    
Weighted average exercise price outstanding, beginning (in usd per share) $ 4.42  
Weighted average exercise price outstanding, nonvested options granted (in usd per share) 4.34  
Weighted average exercise price outstanding, options vested (in usd per share) 4.59  
Weighted average exercise price outstanding, options forfeited (in usd per share) 4.38  
Weighted average exercise price outstanding, ending (in usd per share) $ 4.32  
Weighted average remaining vesting period 2 years 3 months 18 days